CCR2 AAA Pilot Study

Status Terminated

Clinical Trial Summary

The purpose of this research study is to look at whether an investigational imaging agent, 64Cu-DOTA-ECL1i, used during Positron Emission Tomography (PET)/ Computed Tomography (CT) scanning, can help to identify conditions that place patients at an increased risk for AAA rupture. The study is also looking more closely at cellular, molecular and inflammatory properties of the aortic wall. Having the ability to identify markers that predict AAA progression/expansion and risk for rupture could allow the physician to manage patients in a more individualized, personal way.

Clinical Trial Description

Abdominal aortic aneurysm (AAA) is a life-threatening degenerative vascular disease characterized by transmural aortic macrophage infiltration, elastin degradation, and reduction of smooth muscle cell content. AAAs occurs later in life and are especially prevalent in men over the age of 65. Patients typically remain asymptomatic until rupture, which is associated with high mortality. Currently, surgical repair is the only approach for AAA treatment, and there is no pharmacological intervention. Clinically, ultrasound and computed tomography measurement of aneurysm diameter represents the mainstay of management and the principal determinant of timing for elective surgical repair. However, this anatomy-based approach fails to provide useful information about the cellular and molecular processes associated with aneurysm expansion and rupture. Therefore, developing translatable molecular biomarkers, specifically expressed by aneurysms, is necessary to determine associated status and progression, capture the risk of rupture, and deliver personalized treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04592991
Study type	Interventional
Source	Washington University School of Medicine
Contact
Status	Terminated
Phase	Early Phase 1
Start date	October 7, 2020
Completion date	April 4, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01480206` - Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR
Active, not recruiting	`NCT03743142` - Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis In the Treatment of Abdominal Aortic Aneurysms
Active, not recruiting	`NCT02009644` - Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms	N/A
Completed	`NCT01990950` - Fenestrated AAA Endovascular Graft Post-Approval Study	N/A
Withdrawn	`NCT04551183` - Comparative Study of a Software With the Gold Standard	N/A
Completed	`NCT02306304` - Ultra-sound for AAA Screening in Smoking Israeli Arab Men	N/A
Recruiting	`NCT02295137` - Image Fusion of Preprocedural CTA With Real Time Fluoroscopy to Enhance EVAR Repair	Phase 1
Recruiting	`NCT04586452` - NIH CCR2 AAA Study	Early Phase 1
Terminated	`NCT02007252` - ACZ885 for the Treatment of Abdominal Aortic Aneurysm	Phase 2
Completed	`NCT01726257` - Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System	N/A
Completed	`NCT02934087` - Endovascular Aneurysm Repair (EVAR) Gate Study	N/A
Terminated	`NCT03231397` - Predictors of AAA Expansion and/or Rupture	Phase 4
Completed	`NCT04333641` - Development of Novel Imaging Markers Predicting the Progression of Abdominal Aortic Aneurysm Using 3D Computed Tomography